HEADER SIGNALING PROTEIN 14-JUN-21 7OVD TITLE HUMAN SOLUBLE ADENYLYL CYCLASE IN COMPLEX WITH THE INHIBITOR TDI10229 COMPND MOL_ID: 1; COMPND 2 MOLECULE: ADENYLATE CYCLASE TYPE 10; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: AH-RELATED PROTEIN,ADENYLATE CYCLASE HOMOLOG,GERM CELL COMPND 5 SOLUBLE ADENYLYL CYCLASE,SAC,TESTICULAR SOLUBLE ADENYLYL CYCLASE; COMPND 6 EC: 4.6.1.1; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ADCY10, SAC; SOURCE 6 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7111; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: HIGH FIVE CELLS (BTI-TN-5B1-4) KEYWDS SOLUBLE ADENYLYL CYCLASE, ADCY10, SIGNALING ENZYME, CLASS III KEYWDS 2 CYCLASE, SIGNALING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR C.STEEGBORN,J.QUAST REVDAT 3 16-OCT-24 7OVD 1 REMARK REVDAT 2 31-JAN-24 7OVD 1 REMARK REVDAT 1 06-OCT-21 7OVD 0 JRNL AUTH M.FUSHIMI,H.BUCK,M.BALBACH,A.GOROVYY,J.FERREIRA,T.ROSSETTI, JRNL AUTH 2 N.KAUR,L.R.LEVIN,J.BUCK,J.QUAST,J.VAN DEN HEUVEL, JRNL AUTH 3 C.STEEGBORN,E.FINKIN-GRONER,S.KARGMAN,M.MICHINO,M.A.FOLEY, JRNL AUTH 4 M.MILLER,N.J.LIVERTON,D.J.HUGGINS,P.T.MEINKE JRNL TITL DISCOVERY OF TDI-10229: A POTENT AND ORALLY BIOAVAILABLE JRNL TITL 2 INHIBITOR OF SOLUBLE ADENYLYL CYCLASE (SAC, ADCY10). JRNL REF ACS MED.CHEM.LETT. V. 12 1283 2021 JRNL REFN ISSN 1948-5875 JRNL PMID 34413957 JRNL DOI 10.1021/ACSMEDCHEMLETT.1C00273 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.19.2_4158 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 44.39 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.330 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 3 NUMBER OF REFLECTIONS : 28159 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.201 REMARK 3 R VALUE (WORKING SET) : 0.199 REMARK 3 FREE R VALUE : 0.243 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1409 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 44.3900 - 4.7400 1.00 2738 145 0.1835 0.2214 REMARK 3 2 4.7400 - 3.7600 1.00 2697 142 0.1474 0.1981 REMARK 3 3 3.7600 - 3.2900 1.00 2688 141 0.1803 0.2262 REMARK 3 4 3.2800 - 2.9800 1.00 2686 142 0.2004 0.2616 REMARK 3 5 2.9800 - 2.7700 1.00 2679 141 0.2362 0.3165 REMARK 3 6 2.7700 - 2.6100 1.00 2683 141 0.2480 0.2493 REMARK 3 7 2.6100 - 2.4800 1.00 2674 141 0.2618 0.3160 REMARK 3 8 2.4800 - 2.3700 1.00 2678 140 0.2783 0.2894 REMARK 3 9 2.3700 - 2.2800 1.00 2684 142 0.3103 0.3340 REMARK 3 10 2.2800 - 2.2000 0.96 2543 134 0.3363 0.3556 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.324 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 27.399 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 47.88 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 63.23 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 3755 REMARK 3 ANGLE : 1.000 5070 REMARK 3 CHIRALITY : 0.058 557 REMARK 3 PLANARITY : 0.007 647 REMARK 3 DIHEDRAL : 15.933 1352 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 7 THROUGH 108 ) REMARK 3 ORIGIN FOR THE GROUP (A): -36.2117 11.0802 4.4106 REMARK 3 T TENSOR REMARK 3 T11: 0.2833 T22: 0.2523 REMARK 3 T33: 0.2778 T12: 0.0163 REMARK 3 T13: -0.0230 T23: 0.0185 REMARK 3 L TENSOR REMARK 3 L11: 0.3631 L22: 0.5849 REMARK 3 L33: 0.2494 L12: -0.6360 REMARK 3 L13: -0.2716 L23: 0.0919 REMARK 3 S TENSOR REMARK 3 S11: 0.0309 S12: -0.0125 S13: 0.0546 REMARK 3 S21: 0.1284 S22: -0.0259 S23: 0.0556 REMARK 3 S31: 0.0529 S32: 0.0454 S33: 0.0000 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 109 THROUGH 287 ) REMARK 3 ORIGIN FOR THE GROUP (A): -30.8316 6.5771 11.6858 REMARK 3 T TENSOR REMARK 3 T11: 0.3363 T22: 0.2331 REMARK 3 T33: 0.2813 T12: 0.0347 REMARK 3 T13: -0.0272 T23: 0.0253 REMARK 3 L TENSOR REMARK 3 L11: 0.4542 L22: 0.5918 REMARK 3 L33: 1.2965 L12: -0.0806 REMARK 3 L13: 0.0939 L23: -0.5543 REMARK 3 S TENSOR REMARK 3 S11: -0.0423 S12: -0.0735 S13: 0.0395 REMARK 3 S21: -0.0126 S22: 0.0884 S23: -0.0503 REMARK 3 S31: 0.1729 S32: 0.0671 S33: 0.0000 REMARK 3 TLS GROUP : 3 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 288 THROUGH 467 ) REMARK 3 ORIGIN FOR THE GROUP (A): -30.4640 1.8688 -15.4401 REMARK 3 T TENSOR REMARK 3 T11: 0.3433 T22: 0.3267 REMARK 3 T33: 0.2788 T12: 0.0444 REMARK 3 T13: 0.0226 T23: -0.0147 REMARK 3 L TENSOR REMARK 3 L11: 0.0032 L22: 1.1236 REMARK 3 L33: 0.8798 L12: -0.3844 REMARK 3 L13: -0.1687 L23: 0.4591 REMARK 3 S TENSOR REMARK 3 S11: 0.0356 S12: 0.0259 S13: 0.0686 REMARK 3 S21: -0.0778 S22: -0.0522 S23: 0.0469 REMARK 3 S31: 0.1500 S32: 0.0022 S33: 0.0000 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7OVD COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 14-JUN-21. REMARK 100 THE DEPOSITION ID IS D_1292116462. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 29-APR-19 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : BESSY REMARK 200 BEAMLINE : 14.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.98 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 28295 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 44.390 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 200 DATA REDUNDANCY : 11.50 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 6.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.28 REMARK 200 COMPLETENESS FOR SHELL (%) : 95.7 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 5IV4 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.79 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.61 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M TRIPOTASSIUM CITRATE, 20%(W/V) REMARK 280 PEG 3350, VAPOR DIFFUSION, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 63 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z REMARK 290 3555 -X+Y,-X,Z REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+1/2 REMARK 290 6555 X-Y,X,Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 49.79650 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 49.79650 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 49.79650 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2990 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 19510 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 28.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 C ACT A 515 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ASN A 2 REMARK 465 THR A 3 REMARK 465 PRO A 4 REMARK 465 LYS A 5 REMARK 465 GLU A 6 REMARK 465 THR A 132 REMARK 465 GLN A 133 REMARK 465 GLU A 134 REMARK 465 TRP A 135 REMARK 465 GLU A 136 REMARK 465 GLU A 137 REMARK 465 GLY A 138 REMARK 465 LEU A 139 REMARK 465 ASP A 140 REMARK 465 PRO A 351 REMARK 465 GLY A 352 REMARK 465 GLU A 353 REMARK 465 LYS A 468 REMARK 465 VAL A 469 REMARK 465 HIS A 470 REMARK 465 HIS A 471 REMARK 465 HIS A 472 REMARK 465 HIS A 473 REMARK 465 HIS A 474 REMARK 465 HIS A 475 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 PHE A 51 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LYS A 57 CG CD CE NZ REMARK 470 ARG A 142 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 211 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 271 CG CD OE1 OE2 REMARK 470 LYS A 354 CG CD CE NZ REMARK 470 ARG A 465 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 159 -160.34 -111.82 REMARK 500 ASN A 185 4.90 84.71 REMARK 500 ASP A 258 93.77 -170.00 REMARK 500 ASP A 357 57.50 -97.66 REMARK 500 ASP A 357 55.55 -95.71 REMARK 500 LYS A 378 -12.46 79.18 REMARK 500 TYR A 440 -7.67 -57.06 REMARK 500 LYS A 451 80.92 -68.24 REMARK 500 ASP A 455 81.63 44.06 REMARK 500 SER A 456 -47.32 -14.46 REMARK 500 REMARK 500 REMARK: NULL DBREF 7OVD A 1 469 UNP Q96PN6 ADCYA_HUMAN 1 469 SEQADV 7OVD HIS A 470 UNP Q96PN6 EXPRESSION TAG SEQADV 7OVD HIS A 471 UNP Q96PN6 EXPRESSION TAG SEQADV 7OVD HIS A 472 UNP Q96PN6 EXPRESSION TAG SEQADV 7OVD HIS A 473 UNP Q96PN6 EXPRESSION TAG SEQADV 7OVD HIS A 474 UNP Q96PN6 EXPRESSION TAG SEQADV 7OVD HIS A 475 UNP Q96PN6 EXPRESSION TAG SEQRES 1 A 475 MET ASN THR PRO LYS GLU GLU PHE GLN ASP TRP PRO ILE SEQRES 2 A 475 VAL ARG ILE ALA ALA HIS LEU PRO ASP LEU ILE VAL TYR SEQRES 3 A 475 GLY HIS PHE SER PRO GLU ARG PRO PHE MET ASP TYR PHE SEQRES 4 A 475 ASP GLY VAL LEU MET PHE VAL ASP ILE SER GLY PHE THR SEQRES 5 A 475 ALA MET THR GLU LYS PHE SER SER ALA MET TYR MET ASP SEQRES 6 A 475 ARG GLY ALA GLU GLN LEU VAL GLU ILE LEU ASN TYR HIS SEQRES 7 A 475 ILE SER ALA ILE VAL GLU LYS VAL LEU ILE PHE GLY GLY SEQRES 8 A 475 ASP ILE LEU LYS PHE ALA GLY ASP ALA LEU LEU ALA LEU SEQRES 9 A 475 TRP ARG VAL GLU ARG LYS GLN LEU LYS ASN ILE ILE THR SEQRES 10 A 475 VAL VAL ILE LYS CYS SER LEU GLU ILE HIS GLY LEU PHE SEQRES 11 A 475 GLU THR GLN GLU TRP GLU GLU GLY LEU ASP ILE ARG VAL SEQRES 12 A 475 LYS ILE GLY LEU ALA ALA GLY HIS ILE SER MET LEU VAL SEQRES 13 A 475 PHE GLY ASP GLU THR HIS SER HIS PHE LEU VAL ILE GLY SEQRES 14 A 475 GLN ALA VAL ASP ASP VAL ARG LEU ALA GLN ASN MET ALA SEQRES 15 A 475 GLN MET ASN ASP VAL ILE LEU SER PRO ASN CYS TRP GLN SEQRES 16 A 475 LEU CYS ASP ARG SER MET ILE GLU ILE GLU SER VAL PRO SEQRES 17 A 475 ASP GLN ARG ALA VAL LYS VAL ASN PHE LEU LYS PRO PRO SEQRES 18 A 475 PRO ASN PHE ASN PHE ASP GLU PHE PHE THR LYS CYS THR SEQRES 19 A 475 THR PHE MET HIS TYR TYR PRO SER GLY GLU HIS LYS ASN SEQRES 20 A 475 LEU LEU ARG LEU ALA CME THR LEU LYS PRO ASP PRO GLU SEQRES 21 A 475 LEU GLU MET SER LEU GLN LYS TYR VAL MET GLU SER ILE SEQRES 22 A 475 LEU LYS GLN ILE ASP ASN LYS GLN LEU GLN GLY TYR LEU SEQRES 23 A 475 SER GLU LEU ARG PRO VAL THR ILE VAL PHE VAL ASN LEU SEQRES 24 A 475 MET PHE GLU ASP GLN ASP LYS ALA GLU GLU ILE GLY PRO SEQRES 25 A 475 ALA ILE GLN ASP ALA TYR MET HIS ILE THR SER VAL LEU SEQRES 26 A 475 LYS ILE PHE GLN GLY GLN ILE ASN LYS VAL PHE MET PHE SEQRES 27 A 475 ASP LYS GLY CYS SER PHE LEU CYS VAL PHE GLY PHE PRO SEQRES 28 A 475 GLY GLU LYS VAL PRO ASP GLU LEU THR HIS ALA LEU GLU SEQRES 29 A 475 CYS ALA MET ASP ILE PHE ASP PHE CYS SER GLN VAL HIS SEQRES 30 A 475 LYS ILE GLN THR VAL SER ILE GLY VAL ALA SER GLY ILE SEQRES 31 A 475 VAL PHE CYS GLY ILE VAL GLY HIS THR VAL ARG HIS GLU SEQRES 32 A 475 TYR THR VAL ILE GLY GLN LYS VAL ASN LEU ALA ALA ARG SEQRES 33 A 475 MET MET MET TYR TYR PRO GLY ILE VAL THR CYS ASP SER SEQRES 34 A 475 VAL THR TYR ASN GLY SER ASN LEU PRO ALA TYR PHE PHE SEQRES 35 A 475 LYS GLU LEU PRO LYS LYS VAL MET LYS GLY VAL ALA ASP SEQRES 36 A 475 SER GLY PRO LEU TYR GLN TYR TRP GLY ARG THR GLU LYS SEQRES 37 A 475 VAL HIS HIS HIS HIS HIS HIS MODRES 7OVD CME A 253 CYS MODIFIED RESIDUE HET CME A 253 10 HET 1S2 A 501 22 HET ACT A 502 4 HET DMS A 503 4 HET DMS A 504 4 HET DMS A 505 4 HET EDO A 506 4 HET EDO A 507 4 HET ACT A 508 4 HET ACT A 509 4 HET EDO A 510 4 HET DMS A 511 4 HET EDO A 512 4 HET EDO A 513 4 HET EDO A 514 4 HET ACT A 515 4 HETNAM CME S,S-(2-HYDROXYETHYL)THIOCYSTEINE HETNAM 1S2 4-CHLORANYL-6-[1,5-DIMETHYL-4-(PHENYLMETHYL)PYRAZOL-3- HETNAM 2 1S2 YL]PYRIMIDIN-2-AMINE HETNAM ACT ACETATE ION HETNAM DMS DIMETHYL SULFOXIDE HETNAM EDO 1,2-ETHANEDIOL HETSYN 1S2 INHIBITOR TDI10229 HETSYN EDO ETHYLENE GLYCOL FORMUL 1 CME C5 H11 N O3 S2 FORMUL 2 1S2 C16 H16 CL N5 FORMUL 3 ACT 4(C2 H3 O2 1-) FORMUL 4 DMS 4(C2 H6 O S) FORMUL 7 EDO 6(C2 H6 O2) FORMUL 17 HOH *66(H2 O) HELIX 1 AA1 TRP A 11 ALA A 18 1 8 HELIX 2 AA2 PRO A 21 TYR A 26 1 6 HELIX 3 AA3 GLY A 50 SER A 59 1 10 HELIX 4 AA4 SER A 60 MET A 64 5 5 HELIX 5 AA5 ARG A 66 PHE A 89 1 24 HELIX 6 AA6 GLU A 108 LYS A 110 5 3 HELIX 7 AA7 GLN A 111 LEU A 129 1 19 HELIX 8 AA8 GLY A 169 ALA A 182 1 14 HELIX 9 AA9 SER A 190 CYS A 197 1 8 HELIX 10 AB1 ASN A 225 THR A 235 1 11 HELIX 11 AB2 SER A 242 LYS A 246 5 5 HELIX 12 AB3 ARG A 250 LEU A 255 5 6 HELIX 13 AB4 ASP A 258 LYS A 267 1 10 HELIX 14 AB5 MET A 270 ASP A 278 1 9 HELIX 15 AB6 LYS A 306 GLN A 329 1 24 HELIX 16 AB7 ASP A 357 SER A 374 1 18 HELIX 17 AB8 GLY A 408 TYR A 421 1 14 HELIX 18 AB9 ASP A 428 SER A 435 1 8 HELIX 19 AC1 PRO A 438 TYR A 440 5 3 SHEET 1 AA1 5 ASP A 92 ALA A 97 0 SHEET 2 AA1 5 ALA A 100 ARG A 106 -1 O LEU A 102 N LEU A 94 SHEET 3 AA1 5 PHE A 35 SER A 49 -1 N MET A 44 O ALA A 103 SHEET 4 AA1 5 ARG A 142 GLY A 158 -1 O LYS A 144 N ASP A 47 SHEET 5 AA1 5 SER A 163 ILE A 168 -1 O ILE A 168 N SER A 153 SHEET 1 AA2 7 ASP A 92 ALA A 97 0 SHEET 2 AA2 7 ALA A 100 ARG A 106 -1 O LEU A 102 N LEU A 94 SHEET 3 AA2 7 PHE A 35 SER A 49 -1 N MET A 44 O ALA A 103 SHEET 4 AA2 7 ARG A 142 GLY A 158 -1 O LYS A 144 N ASP A 47 SHEET 5 AA2 7 VAL A 187 LEU A 189 1 O ILE A 188 N LEU A 147 SHEET 6 AA2 7 VAL A 213 LEU A 218 -1 O VAL A 213 N LEU A 189 SHEET 7 AA2 7 ILE A 202 SER A 206 -1 N GLU A 205 O LYS A 214 SHEET 1 AA3 5 GLN A 331 PHE A 338 0 SHEET 2 AA3 5 GLY A 341 PHE A 348 -1 O LEU A 345 N LYS A 334 SHEET 3 AA3 5 GLU A 288 MET A 300 -1 N VAL A 295 O CYS A 346 SHEET 4 AA3 5 THR A 381 HIS A 398 -1 O SER A 383 N ASN A 298 SHEET 5 AA3 5 ARG A 401 ILE A 407 -1 O ARG A 401 N HIS A 398 SHEET 1 AA4 7 GLN A 331 PHE A 338 0 SHEET 2 AA4 7 GLY A 341 PHE A 348 -1 O LEU A 345 N LYS A 334 SHEET 3 AA4 7 GLU A 288 MET A 300 -1 N VAL A 295 O CYS A 346 SHEET 4 AA4 7 THR A 381 HIS A 398 -1 O SER A 383 N ASN A 298 SHEET 5 AA4 7 VAL A 425 CYS A 427 1 O THR A 426 N ILE A 384 SHEET 6 AA4 7 TYR A 460 TYR A 462 -1 O TYR A 462 N VAL A 425 SHEET 7 AA4 7 PHE A 442 GLU A 444 -1 N LYS A 443 O GLN A 461 LINK C ALA A 252 N CME A 253 1555 1555 1.33 LINK C CME A 253 N THR A 254 1555 1555 1.34 CISPEP 1 ARG A 33 PRO A 34 0 3.68 CRYST1 99.177 99.177 99.593 90.00 90.00 120.00 P 63 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010083 0.005821 0.000000 0.00000 SCALE2 0.000000 0.011643 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010041 0.00000